| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.3 | 0.04 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |